Life Sciences Insights

Life Sciences Insights

LumiraDx to Go Public on Nasdaq Through SPAC

Special purpose acquisition company (SPAC) CA Healthcare Acquisition on Wednesday announced a merger agreement with point-of-care diagnostic testing firm LumiraDx. The merger with CA Healthcare Acquisition would facilitate the listing

Read More »